van Vollenhoven RF - Search Results

1

Treat-to-target in systemic lupus erythematosus: advancing towards its implementation.

Parra Sánchez AR, Voskuyl AE, van Vollenhoven RF. Parra Sánchez AR, et al. Among authors: van vollenhoven rf. Nat Rev Rheumatol. 2022 Mar;18(3):146-157. doi: 10.1038/s41584-021-00739-3. Epub 2022 Jan 17. Nat Rev Rheumatol. 2022. PMID: 35039665 Review.

2

An open study of dehydroepiandrosterone in systemic lupus erythematosus.

van Vollenhoven RF, Engleman EG, McGuire JL. van Vollenhoven RF, et al. Arthritis Rheum. 1994 Sep;37(9):1305-10. doi: 10.1002/art.1780370906. Arthritis Rheum. 1994. PMID: 7945493 Clinical Trial.

3

Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial.

van Vollenhoven RF, Engleman EG, McGuire JL. van Vollenhoven RF, et al. Arthritis Rheum. 1995 Dec;38(12):1826-31. doi: 10.1002/art.1780381216. Arthritis Rheum. 1995. PMID: 8849355 Clinical Trial.

4

Studies of dehydroepiandrosterone (DHEA) as a therapeutic agent in systemic lupus erythematosus.

Van Vollenhoven RF, McGuire JL. Van Vollenhoven RF, et al. Ann Med Interne (Paris). 1996;147(4):290-6. Ann Med Interne (Paris). 1996. PMID: 8952750 Review.

5

Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months.

van Vollenhoven RF, Morabito LM, Engleman EG, McGuire JL. van Vollenhoven RF, et al. J Rheumatol. 1998 Feb;25(2):285-9. J Rheumatol. 1998. PMID: 9489820 Clinical Trial.

6

Socioeconomic status and health in women with systemic lupus erythematosus.

Lotstein DS, Ward MM, Bush TM, Lambert RE, van Vollenhoven R, Neuwelt CM. Lotstein DS, et al. J Rheumatol. 1998 Sep;25(9):1720-9. J Rheumatol. 1998. PMID: 9733452

7

Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response.

Barry NN, McGuire JL, van Vollenhoven RF. Barry NN, et al. Among authors: van vollenhoven rf. J Rheumatol. 1998 Dec;25(12):2352-6. J Rheumatol. 1998. PMID: 9858429 Clinical Trial.

8

VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics.

van Vollenhoven RF, Bieber MM, Powell MJ, Gupta PK, Bhat NM, Richards KL, Albano SA, Teng NN. van Vollenhoven RF, et al. J Rheumatol. 1999 Aug;26(8):1727-33. J Rheumatol. 1999. PMID: 10451069

9

Psychosocial correlates of morbidity in women with systemic lupus erythematosus.

Ward MM, Lotstein DS, Bush TM, Lambert RE, van Vollenhoven R, Neuwelt CM. Ward MM, et al. J Rheumatol. 1999 Oct;26(10):2153-8. J Rheumatol. 1999. PMID: 10529132

10

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints.

Bertsias GK, Ioannidis JP, Boletis J, Bombardieri S, Cervera R, Dostal C, Font J, Gilboe IM, Houssiau F, Huizinga T, Isenberg D, Kallenberg CG, Khamashta M, Piette JC, Schneider M, Smolen J, Sturfelt G, Tincani A, van Vollenhoven R, Boumpas DT, Gordon C. Bertsias GK, et al. Ann Rheum Dis. 2009 Apr;68(4):477-83. doi: 10.1136/ard.2007.083030. Epub 2008 Apr 23. Ann Rheum Dis. 2009. PMID: 18434449 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

486 results

Search Page